In This Article:
As the United States stock market navigates a volatile period marked by fluctuations in major indices and a notable slump in big-tech stocks, investors are increasingly focused on identifying resilient growth opportunities. In this environment, companies with substantial insider ownership can offer unique insights into potential value creation, as insiders' vested interests often align with long-term shareholder success.
Top 10 Growth Companies With High Insider Ownership In The United States
Name | Insider Ownership | Earnings Growth |
Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 25.7% |
Super Micro Computer (NasdaqGS:SMCI) | 14.4% | 24.3% |
On Holding (NYSE:ONON) | 19.1% | 29.4% |
Duolingo (NasdaqGS:DUOL) | 14.6% | 34.7% |
Clene (NasdaqCM:CLNN) | 21.6% | 59.2% |
EHang Holdings (NasdaqGM:EH) | 32.8% | 81.8% |
BBB Foods (NYSE:TBBB) | 22.9% | 41% |
Credo Technology Group Holding (NasdaqGS:CRDO) | 13.3% | 66.3% |
Credit Acceptance (NasdaqGS:CACC) | 14.0% | 49% |
Spotify Technology (NYSE:SPOT) | 17.6% | 29.7% |
Let's dive into some prime choices out of the screener.
Delcath Systems
Simply Wall St Growth Rating: ★★★★★☆
Overview: Delcath Systems, Inc. is an interventional oncology company specializing in the treatment of primary and metastatic liver cancers in the United States and Europe, with a market cap of $382.41 million.
Operations: The company's revenue segment focuses on the development and commercialization of Melphalan/HDS and CHEMOSAT, generating $22.64 million.
Insider Ownership: 11.6%
Delcath Systems is positioned for growth with revenue forecasted to increase by 40.5% annually, outpacing the broader U.S. market. The company recently reported a turnaround in its financials with a net income of US$1.86 million for Q3 2024, compared to a significant loss the previous year. Despite past shareholder dilution and limited cash runway, Delcath's FDA-approved Phase 2 trial for HEPZATO™ could enhance its market presence in liver-dominant metastatic colorectal cancer treatment.
-
Click to explore a detailed breakdown of our findings in Delcath Systems' earnings growth report.
-
Upon reviewing our latest valuation report, Delcath Systems' share price might be too pessimistic.
EHang Holdings
Simply Wall St Growth Rating: ★★★★★★
Overview: EHang Holdings Limited is an autonomous aerial vehicle technology platform company operating in China, East Asia, West Asia, Europe, and internationally with a market cap of approximately $1.01 billion.
Operations: The company's revenue segment is Aerospace & Defense, generating CN¥348.48 million.